Interestingly, the 22 proteins with different levels in AD versus non-AD CSF biomarker profiles (Fig. 2a) were all associated with CSF tau; a large majority were associated with CSF P-tau181; but none were associated with CSF Aβ1–42 (Additional file 1: Figure S6). This evidence concerns the gene MAPT and Alzheimer disease.